Effects on Recovery of Postoperative Gastrointestinal Function With Multimodal Analgesia
关键词
抽象
描述
thrity patients participated in this randomized, single-blined study. Before and at the postoperative day 1, the bowel function (orocecal transmit time) were measured. Before induction of general anesthesia, patients recieved a bolus of intravenous Tenoxicam or an equal volume of saline (control group). Pain score and opioid consumption were recorded in the postoperative period and then daily for 1 week.
日期
| 最后验证: | 02/29/2020 |
| 首次提交: | 03/16/2020 |
| 提交的预估入学人数: | 03/16/2020 |
| 首次发布: | 03/18/2020 |
| 上次提交的更新: | 03/16/2020 |
| 最近更新发布: | 03/18/2020 |
| 实际学习开始日期: | 03/22/2020 |
| 预计主要完成日期: | 12/30/2022 |
| 预计完成日期: | 12/30/2025 |
状况或疾病
干预/治疗
Drug: Tenoxicam
Drug: placebo
相
手臂组
| 臂 | 干预/治疗 |
|---|---|
| Active Comparator: Tenoxicam nonsteroidal anti-inflammatory drug (NSAID) | Drug: Tenoxicam nonsteroidal anti-inflammatory drug (NSAID) |
| Placebo Comparator: placebo equal volume of normal saline | Drug: placebo equal volume of normal saline |
资格标准
| 有资格学习的年龄 | 40 Years 至 40 Years |
| 有资格学习的性别 | Female |
| 接受健康志愿者 | 是 |
| 标准 | Inclusion Criteria: - ASA I to II Breast cancer patients Mastectomy or wide local excision + axillary note dissection Exclusion Criteria: - Preexisting malignancy Chronic infection Previous pain condition Diabetes Thyroid disorder Severe cardiac, renal or hepatic disease Previous breast surgery Psychiatric illness Neurological disease Contraindication for tenoxicam or morphine use |
结果
主要结果指标
1. morphine consumption [until postoperative day7]
次要成果指标
1. orocecal transmit time, [preoperative and postoperative day 1]
